Company Profiles

driven by the PitchBook Platform

PharmaNeuroBoost

Description

Developer of central nervous system therapeutics. The company is currently researching its two main anti-depression drugs: PNB01 and PNB02, which are combination medicines that strive to reinforce the effect of SSRIs, an important class of anti-depressants (PNB01) and of atypical antipsychotics (PNB02).

2006

Founded

PRIVATE

Status

Early Stage VC

Latest Deal Type

$20M

Latest Deal Amount

$30.7M

Total Amount Raised

2

Investors

Description

Developer of central nervous system therapeutics. The company is currently researching its two main anti-depression drugs: PNB01 and PNB02, which are combination medicines that strive to reinforce the effect of SSRIs, an important class of anti-depressants (PNB01) and of atypical antipsychotics (PNB02).

Website:

pharmaneuroboost.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

Alkerstraat 30 A 3570 AlkenBelgium +32 (0)1 148 07 50
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore PharmaNeuroBoost's full profile, request a free trial.

    PharmaNeuroBoost Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    PharmaNeuroBoost Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Biovest (Belgium)Venture CapitalMinority000 0000000 0000
    KBC Private EquityPE/BuyoutMinority000 0000000 0000
    Biovest (Belgium) Venture Capital
    KBC Private Equity PE/Buyout

    PharmaNeuroBoost Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Remi Broeck MDPresident & Chief Development Officer
    Didier Chaffoy Ph.DChief Scientific Officer
    Lieven Baert Ph.DChief Executive Officer
    Patricia Baede Ph.DDirector Regulatory Affairs
    Philippe Lemmens Ph.DDirector, Clinical Development
    Remi Broeck MD President & Chief Development Officer
    Didier Chaffoy Ph.D Chief Scientific Officer
    Lieven Baert Ph.D Chief Executive Officer
    Patricia Baede Ph.D Director Regulatory Affairs
    Philippe Lemmens Ph.D Director, Clinical Development

    PharmaNeuroBoost Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Jo BreeshSelfBoard Member000 0000
    Rudi MarienSelfBoard Member000 0000
    Jo Breesh Board Member Self
    Rudi Marien Board Member Self
    Request full access to PitchBook